Caitong International Asset Management Co., LTD Eye Point Pharmaceuticals, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $102 Billion
- Q4 2024
A detailed history of Caitong International Asset Management Co., LTD transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 35 shares of EYPT stock, worth $227. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35
Previous 35
-0.0%
Holding current value
$227
Previous $261,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding EYPT
# of Institutions
151Shares Held
65.9MCall Options Held
143KPut Options Held
173K-
Cormorant Asset Management, LP Boston, MA8.33MShares$54.1 Million4.9% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.78MShares$44.1 Million2.1% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.75MShares$37.4 Million0.08% of portfolio
-
Franklin Resources Inc San Mateo, CA4.14MShares$26.9 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.8MShares$24.7 Million0.0% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $221M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...